Fundraising Fox1 people tracked
Also known as Unicorn Capital
Find your way into Unicorn Capital Partners
Sign up to see every warm intro you have to Unicorn Capital Partners
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Unicorn Capital Partners team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Unicorn Capital Partners invests in biotechnology companies with a focus on scientific innovation. The firm's track record shows strong exit outcomes, with nine of eleven portfolio companies achieving NASDAQ listings. The investment thesis centers on identifying promising biotech ventures through relationships with leading global venture firms including Third Rock Ventures, JJDC, Pfizer Ventures, Bessemer Venture Partners, and others.
Source: firm website, verified Oct 4, 2026.
Team · 1 people
from the firm's websiteWhat they invest in
from 1 of 2 portfolio companiesBiotech ×1
HQs:United States×1
Investments · 2 tracked
founders shown can be your intro pathBy year:2024 · 12022 · 12 dated
Nigerian digital media company creating engaging content for African youth audiences.
Co-investorsFuture AfricaMaC Venture CapitalRising Tide Africa (RTA)Luminate
Bluejay is a biotechnology company focused on therapeutic development.
BiotechSan Mateo, US
Keting Chu(Founder, Chief Executive Officer and Chairman of the Board)inDajun Yang(Director)Nancy Hong(Director)inAlon Lazarus(Director)William J. Rutter(Director)Ting Jia(Director)
Co-investorsFrazier Life SciencesRA CapitalRiverVest Venture PartnersWellington ManagementFrazier Healthcare PartnersHBM Healthcare Investments+2 more
Exits · 1
1 acquisitionsBluejaytxacq. by Mirum Pharmaceuticals
Frequently asked questions
- What sectors does Unicorn Capital Partners focus on?
- Unicorn Capital Partners focuses on Biotech.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.